Shares of Sappi Limited surged +12% to ZAc 1,407 on August 7, extending a five-day rally of more than 22%, after the South African pulp and packaging group posted third-quarter results that were poor on their own but carried a forward-looking message investors had been waiting months to hear: the worst may be over.

A Weak Quarter, but One That Met Already-Lowered Expectations

Sappi acknowledged "challenging market conditions with volatile economic macro factors" that hit both costs and selling prices. The $53 million in adjusted EBITDA — a rough measure of operating cash flow — matched management's revised guidance but was 34% below the same period last year. The net debt leverage ratio sat at roughly 6x EBITDA , a dangerous level for any cyclical manufacturer. Leverage covenant testing remains suspended until March 2027, and the ratio stood at 6.9x as of June 2026. In short, the company is operating with a very thin financial cushion.

$120 Million in Cost Cuts Gives Management Room to Breathe Year-to-date cost reductions of $120 million are doing what price increases alone cannot in a market plagued by oversupply. European cost-saving measures are expected to yield €60 million in savings against €40 million in implementation costs.

Sappi is also paring back capital expenditure to below $300 million annually and freezing major growth projects through 2027. Those savings go directly toward chipping away at roughly $2 billion in net debt.

The UPM Joint Venture Could Reshape Sappi's Future — If Regulators Allow It

In May, Sappi and Finnish rival UPM signed a definitive agreement on a 50/50 graphic paper joint venture targeting at least €100 million in annual synergies.

The European Commission opened a Phase II investigation in April , meaning antitrust scrutiny will be intense. If completed, the deal would reduce Sappi's direct graphic paper exposure to below 20% of sales , shifting the company toward higher-margin packaging and specialty products.

What to Watch Next Management's promise that fourth-quarter EBITDA will be materially above Q3 is the bet the market is pricing in today. But with leverage near 7x and Fitch having downgraded Sappi to BB after gross leverage hit 4.5x at FY2025 year-end , even a good quarter won't eliminate the balance-sheet overhang. The stock's rally is a wager on trajectory, not arrival.